| c-Jun overexpression in CAR T cells induces exhaustion resistance RC Lynn, EW Weber, E Sotillo, D Gennert, P Xu, Z Good, H Anbunathan, ... Nature 576 (7786), 293-300, 2019 | 601 | 2019 |
| Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma JW Harbour, EDO Roberson, H Anbunathan, MD Onken, LA Worley, ... Nature Genetics, 2013 | 546 | 2013 |
| Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling EW Weber, KR Parker, E Sotillo, RC Lynn, H Anbunathan, J Lattin, ... Science 372 (6537), 2021 | 400* | 2021 |
| Driver mutations in uveal melanoma: associations with gene expression profile and patient outcomes CL Decatur, E Ong, N Garg, H Anbunathan, AM Bowcock, MG Field, ... JAMA ophthalmology 134 (7), 728-733, 2016 | 256 | 2016 |
| Punctuated evolution of canonical genomic aberrations in uveal melanoma MG Field, MA Durante, H Anbunathan, LZ Cai, CL Decatur, AM Bowcock, ... Nature communications 9 (1), 116, 2018 | 178 | 2018 |
| GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity S Heitzeneder, KR Bosse, Z Zhu, D Zhelev, RG Majzner, MT Radosevich, ... Cancer Cell 40 (1), 53-69. e9, 2022 | 99 | 2022 |
| Mutant MYO1F alters the mitochondrial network and induces tumor proliferation in thyroid cancer C Diquigiovanni, C Bergamini, C Evangelisti, F Isidori, A Vettori, N Tiso, ... International journal of cancer 143 (7), 1706-1719, 2018 | 46 | 2018 |
| CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts M Ammar, CT Jordan, L Cao, E Lim, C Bouchlaka Souissi, A Jrad, ... British Journal of Dermatology 174 (2), 330-337, 2016 | 40 | 2016 |
| Integrated genomics point to immune vulnerabilities in pleural mesothelioma A Nastase, A Mandal, SK Lu, H Anbunathan, D Morris-Rosendahl, ... Scientific Reports 11 (1), 19138, 2021 | 24* | 2021 |
| Genome‐wide linkage scan for psoriasis susceptibility loci in multiplex Tunisian families M Ammar, C Bouchlaka‐Souissi, CA Helms, I Zaraa, CT Jordan, ... British Journal of Dermatology, 2013 | 23 | 2013 |
| Integrative copy number analysis of uveal melanoma reveals novel candidate genes involved in tumorigenesis including a tumor suppressor role for PHF10/BAF45a H Anbunathan, R Verstraten, AD Singh, JW Harbour, AM Bowcock Clinical Cancer Research, clincanres. 3052.2018, 2019 | 20 | 2019 |
| The Molecular Revolution in Cutaneous Biology: The Era of Genome-Wide Association Studies and Statistical, Big Data, and Computational Topics H Anbunathan, AM Bowcock Journal of Investigative Dermatology 137 (5), e113–e118, 2017 | 20 | 2017 |
| Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy S Kaczanowska, T Murty, A Alimadadi, CF Contreras, C Duault, ... Cancer Cell 42 (1), 35-51. e8, 2024 | 11 | 2024 |
| Validation of a Specific Missense GTF2I Mutation in More Indolent Thymic Epithelial Tumours S Gennatas, H Anbunathan, A Montero, AG Nicholson, S Popat, ... JOURNAL OF THORACIC ONCOLOGY 10 (9), S403-S403, 2015 | 2 | 2015 |
| Molecular landscape of malignant mesothelioma from whole exome sequencing SK Lu, H Anbunathan, S Popat, MER O'Brien, E Lim, AM Fernandez, ... JOURNAL OF THORACIC ONCOLOGY 10 (9), S253-S253, 2015 | 1 | 2015 |
| A novel, high-throughput full-length scRNA-seq workflow for improved biomarker discovery P Xu, J Liu, Y Ryan, K Tori, X Li, H Anbunathan, M Covington, T Uchiyama, ... Cancer Research 84 (6_Supplement), 316-316, 2024 | | 2024 |
| Demystifying tumor heterogeneity with a fully automated, high-throughput single-cell DNA-Seq (scDNA-seq) workflow X Li, R Mendoza, S Leong, H Anbunathan, M Covington, M Fallahi, B Bell, ... Cancer Research 84 (6_Supplement), 318-318, 2024 | | 2024 |
| Utilizing response in immune checkpoint inhibitor treated cohorts improves clinical applicability of neoantigen immunogenicity predictions H Anbunathan, N Ravi, RM Pyke, S Dea, RO Chen, SM Boyle Cancer Research 83 (7_Supplement), 5472-5472, 2023 | | 2023 |
| 51 A combination of antigen presentation and T-cell recognition features improves neoantigen immunogenicity predictions N Ravi, H Anbunathan, RM Pyke, S Dea, P Tandon, RO Chen, SM Boyle Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| 119 Sensitive prediction of immunotherapy response by integrating immune infiltration and neoantigen presentation score in late-stage melanoma B Li, C Abbott, L McDaniel, R Pyke, F Navarro, H Anbunathan, M Synder, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
